Antiangiogenic agent, thalidomide increases the antitumor effect of single high dose irradiation (gamma knife radiosurgery) in the rat orthotopic glioma model

Oncology Reports

Volumn 15, Issue 5, 2006, Pages 1163-1168

  Lee, Jung Il ^a   Itasaka, Satoshi ^c   Kim, Ji Tae ^a,b   Nam, Do Hyun ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Korea Institute of Radiation and Medical Science   (South Korea)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Antiangiogenic treatment; Gamma knife radiosurgery; Glioma; Orthotopic model; Thalidomide

Indexed keywords

ANGIOGENESIS INHIBITOR; DACARBAZINE; DRUG DERIVATIVE; TEMOZOLOMIDE; THALIDOMIDE;

ANIMAL; APOPTOSIS; ARTICLE; BRAIN TUMOR; CELL PROLIFERATION; DISEASE MODEL; DRUG COMBINATION; DRUG EFFECT; DRUG POTENTIATION; GLIOMA; MALE; MICROCIRCULATION; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RADIATION EXPOSURE; RADIATION RESPONSE; RADIOSURGERY; RAT; SPRAGUE DAWLEY RAT;

ANGIOGENESIS INHIBITORS; ANIMALS; APOPTOSIS; BRAIN NEOPLASMS; CELL PROLIFERATION; COMBINED MODALITY THERAPY; DACARBAZINE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; GLIOMA; MALE; MICROCIRCULATION; RADIOSURGERY; RATS; RATS, SPRAGUE-DAWLEY; THALIDOMIDE;

EID: 33744971175     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.15.5.1163     Document Type: Article

References (30)

1. Prados MD and Levin V: Biology and treatment of malignant glioma. Semin Oncol 27: 1-10, 2000. (Pubitemid 30390229)
2. Fine HA, Dear KB, Loeffler JS, Black PM and Canellos GP: Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71: 2585-2597, 1993. (Pubitemid 23100496)
3. Stewart LA: Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 359: 1011-1018, 2002.
4. Souhami L, Seiferheld W, Brachman D, Podgorsak EB, Werner-Wasik M, Lustig R, Schultz CJ, Sause W, Okunieff P, Buckner J, Zamorano L, Mehta MP and Curran WJ Jr: Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol. Int J Radiat Oncol Biol Phys 60: 853-860, 2004. (Pubitemid 39311766)
5. Garcia-Barros M, Paris F, Cordon-Cardo C, Lyden D, Rafii S, Haimovitz-Friedman A, Fuks Z and Kolesnick R: Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300: 1155-1159, 2003. (Pubitemid 36583102)
6. Moeller BJ, Cao Y, Li CY and Dewhirst MW: Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules. Cancer Cell 5: 429-441, 2004. (Pubitemid 38610245)
7. Gorski DH, Beckett MA, Jaskowiak NT, et al: Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res 59: 3374-3378, 1999. (Pubitemid 29334495)
8. Geng L, Donnelly E, McMahon G, Lin PC, Sierra-Rivera E, Oshinka H and Hallahan DE: Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy. Cancer Res 61: 2413-2419, 2001. (Pubitemid 32685816)
9. Hess C, Vuong V, Hegyi I, Riesterer O, Wood J, Fabbro D, Glanzmann C, Bodis S and Pruschy M: Effect of VEGF receptor inhibitor PTK787/ZK222584 (correction of ZK222548) combined with ionizing radiation on endothelial cells and tumour growth. Br J Cancer 85: 2010-2016, 2001. (Pubitemid 34775341)
10. Kaur B, Tan C, Brat DJ, Post DE and Van Meir EG: Genetic and hypoxic regulation of angiogenesis in gliomas. J Neurooncol 70: 229-243, 2004. (Pubitemid 39545734)
11. Parthymou A, Kardamakis D, Pavlopoulos I and Papadimitriou E: Irradiated C6 glioma cells induce angiogenesis in vivo and activate endothelial cells in vitro . Int J Cancer 110: 807-814, 2004. (Pubitemid 38758505)
12. Bartlett JB, Dredge K and Dalgleish AG: The evolution of thalidomide and its IMiD derivatives as anticancer agents. Nat Rev Cancer 4: 314-322, 2004. (Pubitemid 38525287)
13. Kenyon BM, Browne F and D'Amato RJ: Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization. Exp Eye Res 64: 971-978, 1997. (Pubitemid 27314772)
14. Kruse FE, Joussen AM, Rohrschneider K, Becker MD and Volcker HE: Thalidomide inhibits corneal angiogenesis induced by vascular endothelial growth factor. Graefes Arch Clin Exp Ophthalmol 236: 461-466, 1998. (Pubitemid 28269042)
15. D'Amato RJ, Loughnan MS, Flynn E and Folkman J: Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 91: 4082-4085, 1994. (Pubitemid 24139577)
16. Short SC, Traish D, Dowe A, Hines F, Gore M and Brada M: Thalidomide as an anti-angiogenic agent in relapsed gliomas. J Neurooncol 51: 41-45, 2001. (Pubitemid 32321900)
17. Fine HA, Wen PY, Maher EA, Viscosi E, Batchelor T, Lakhani N, Figg WD, Purow BW and Borkowf CB: Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomas. J Clin Oncol 21: 2299-2304, 2003. (Pubitemid 46621867)
18. Mauceri HJ, Hanna NN, Beckett MA, Gorski DH, Staba MJ, Stellato KA, Bigelow K, Heimann R, Gately S, Dhanabal M, Soff GA, Sukhatme VP, Kufe DW and Weichselbaum RR: Combined effects of angiostatin and ionizing radiation in antitumour therapy. Nature 394: 287-291, 1998. (Pubitemid 28335042)
19. Gorski DH, Mauceri HJ, Salloum RM, Gately S, Hellman S, Beckett MA, Sukhatme VP, Soff GA, Kufe DW and Weichselbaum RR: Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin. Cancer Res 58: 5686-5689, 1998. (Pubitemid 29006406)
20. Newlands ES, Stevens MF, Wedge SR, Wheelhouse RT and Brock C: Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials. Cancer Treat Rev 23: 35-61, 1997. (Pubitemid 27273454)
21. Stupp R, Dietrich PY, Ostermann Kraljevic S, Pica A, Maillard I, Maeder P, Meuli R, Janzer R, Pizzolato G, Miralbell R, Porchet F, Regli L, de Tribolet N, Mirimanoff RO and Leyvraz S: Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol 20: 1375-1382, 2002. (Pubitemid 34177445)
22. Stupp R, Mason WP, van den Bent MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996, 2005. (Pubitemid 40349501)
23. Nam DH, Park K, Park C, Im YH, Kim MH, Lee S, Hong SC, Shin HJ, Kim JH, Eoh W and McDonnell TJ: Intracranial inhibition of glioma cell growth by cyclooxygenase-2 inhibitor celecoxib. Oncol Rep 11: 263-268, 2004.
24. Lal S, Lacroix M, Tofilon P, Fuller GN, Sawaya R and Lang FF: An implantable guide-screw system for brain tumor studies in small animals. J Neurosurg 92: 326-333, 2000. (Pubitemid 30071053)
25. Brown CK, Khodarev NN, Yu J, Moo-Young T, Labay E, Darga TE, Posner MC, Weichselbaum RR and Mauceri HJ: Glioblastoma cells block radiation-induced programmed cell death of endothelial cells. FEBS Lett 565: 167-170, 2004. (Pubitemid 38595340)
26. Ansiaux R, Baudelet C, Jordan BF, Beghein N, Sonveaux P, De Wever J, Martinive P, Gregoire V, Feron O and Gallez B: Thalidomide radiosensitizes tumors through early changes in the tumor microenvironment. Clin Cancer Res 11: 743-750, 2005. (Pubitemid 40116903)
27. Paris F, Fuks Z, Kang A, Capodieci P, Juan G, Ehleiter D, Haimovitz-Friedman A, Cordon-Cardo C and Kolesnick R: Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 293: 293-297, 2001. (Pubitemid 32694744)
28. Son MJ, Kim JS, Kim MH, Song HS, Kim JT, Kim H, Shin T, Jeon HJ, Lee DS, Park SY, Kim YJ, Kim JH and Nam DH: Combination treatment with temozolomide and thalidomide inhibits tumor growth and angiogenesis in an orthotopic glioma model. Int J Oncol 28: 53-59, 2006.
29. Jain RK: Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nat Med 7: 987-989, 2001.
30. Jain RK: Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307: 58-62, 2005.